To the full analysis
Aperam stock: growth
APAM.ASAperam reported $6.74B in revenue for fiscal 2025, down 2.8% on the prior year, up 10.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−0.2%
per year from 2007 to 2025, per share 0.2%
Earnings (Annual rate)
−17.3%
per year from 2007 to 2025, per share −17.1%
Free cash flow (Annual rate)
−5.3%
per year from 2007 to 2025, per share −4.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2007 | |
|---|---|---|---|
| Revenue | 10.9% | 3.5% | −0.2% |
| Revenue per share | 13.1% | 4.3% | 0.2% |
| Earnings | −44.8% | −24.9% | −17.3% |
| Earnings per share | −44.1% | −24.6% | −17.1% |
| Free cash flow | 8.0% | 1.8% | −5.3% |
| Free cash flow per share | 10.2% | 2.6% | −4.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $7.01B | $302.48M | $843.61M |
| 2008 | $6.65B | $46.96M | $191.04M |
| 2009 | $3.28B | −$92.81M | $76.57M |
| 2010 | $4.67B | $87.48M | $217.46M |
| 2011 | $5.42B | −$51.3M | $26.5M |
| 2012 | $4.41B | −$90.49M | $98.03M |
| 2013 | $4.11B | −$80.25M | $63.39M |
| 2014 | $5B | $86.57M | $124.84M |
| 2015 | $4.78B | $174.33M | $263.52M |
| 2016 | $4.49B | $225.48M | $302.39M |
| 2017 | $4.67B | $333.44M | $234.61M |
| 2018 | $5.18B | $316.92M | $114.13M |
| 2019 | $4.7B | $164M | $275.92M |
| 2020 | $4.02B | $193.92M | $214.97M |
| 2021 | $5.65B | $1.07B | $441.02M |
| 2022 | $9.04B | $692.56M | $383.4M |
| 2023 | $7.3B | $224.94M | $188.38M |
| 2024 | $6.93B | $255.97M | $126.32M |
| 2025 | $6.74B | $9.97M | $315.81M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 11 Nov 2026, previously Weak
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.